Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/03/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/03/11 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
85 | |
| 11/03/11 | SC 13D | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
37 | |
| 11/02/11 | 5 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 11/02/11 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/02/11 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/02/11 | 5 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 11/02/11 | 5 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 11/02/11 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/02/11 | 4 | Statement of changes in beneficial ownership of securities |
|
3 |
